| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/19/2002 | US6358971 Anti-viral compounds |
| 03/19/2002 | US6358970 Integrin receptor antagonists |
| 03/19/2002 | US6358951 Administering pyrazolo(4,3-c)pyridine derivative to treat obesity, congestive heart failure, osteoporosis, aging, bone and muscular disorders |
| 03/19/2002 | US6358949 Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors |
| 03/19/2002 | US6358946 C-6 ring-substituted pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders |
| 03/19/2002 | US6358885 Preemergent or postemergent herbicides or plant growth regulants |
| 03/19/2002 | US6358746 Fluorescent compounds for use in industrial water systems |
| 03/19/2002 | US6358696 Methods of treatment of eye trauma and disorders |
| 03/19/2002 | US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device |
| 03/14/2002 | WO2002020524A1 Oxindole derivatives |
| 03/14/2002 | WO2002020523A1 Process for preparing a substituted imidazopyridine compound |
| 03/14/2002 | WO2002020522A1 Bicyclic enamide derivatives being integrin inhibitors |
| 03/14/2002 | WO2002020515A1 Oxazolidinone antibacterial agents |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |
| 03/14/2002 | WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/14/2002 | WO2002020484A1 Chemical compounds |
| 03/14/2002 | WO2002020013A2 A method for treating allergies using substituted pyrazoles |
| 03/14/2002 | WO2002020012A2 Method for treating allergies using substituted pyrazoles |
| 03/14/2002 | WO2002020011A2 A method for treating allergies using substituted pyrazoles |
| 03/14/2002 | WO2001082909A3 2-acyl indol derivatives and their use as anti-tumour agents |
| 03/14/2002 | WO2001074790A3 Novel compounds for enhancing chemotherapy |
| 03/14/2002 | WO2001051486A3 Process and intermediates for the preparation of imidazopyridines |
| 03/14/2002 | WO2001047918A3 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides |
| 03/14/2002 | WO2001038302A3 Coupling condensation synthesis of heterocycles |
| 03/14/2002 | US20020032216 7-(3-Aminomethyl-4-methoxyiminopyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate and hydrates thereof; use in antibacterial therapy. |
| 03/14/2002 | US20020032205 An alkyl amine substituted isobenzofuran compound useful for certain psychiatric and neurological disorders; potently binding to the 5-HT1A receptor |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032200 2-Substituted imidazo[1,2-A]pyridine derivatives |
| 03/14/2002 | US20020032196 CRF receptor antagonists and methods relating thereto |
| 03/14/2002 | CA2421510A1 A method for treating allergies using substituted pyrazoles |
| 03/14/2002 | CA2421505A1 Method for treating allergies using substituted pyrazoles |
| 03/14/2002 | CA2421493A1 A method for treating allergies using substituted pyrazoles |
| 03/13/2002 | EP1186603A2 Processes for preparing endothelin antagonists |
| 03/13/2002 | EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist |
| 03/13/2002 | EP1186293A2 Intermittent administration of a growth hormone secretagogue |
| 03/13/2002 | EP1185536A2 Hemisynthetic method and intermediates thereof |
| 03/13/2002 | EP1185516A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 03/13/2002 | EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| 03/13/2002 | EP0858452B1 Thiazole derivative as protein kinase c inhibitors |
| 03/13/2002 | EP0596897B1 Hydroisoquinoline derivatives |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355802 Intermediates for drug to treat parkinson*s disease |
| 03/12/2002 | US6355799 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 03/12/2002 | US6355653 Amino-triazolopyridine derivatives |
| 03/12/2002 | US6355651 Certain pyrrolopyridine derivatives; novel CRF1 specific ligands |
| 03/12/2002 | US6355641 Oxazolone derivatives and uses thereof |
| 03/12/2002 | US6355640 Pyrazolopyridine adenosine antagonists |
| 03/12/2002 | US6355636 Enzyme inhibitors |
| 03/12/2002 | CA2137889C Eburnan analogs; process for preparing the same and pharmaceutical compositions containing them |
| 03/07/2002 | WO2002019213A2 Method for treatment of migraine using pde5 inhibitors |
| 03/07/2002 | WO2002018383A2 Aza heterocyclic derivatives and their therapeutic use |
| 03/07/2002 | WO2002018382A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 03/07/2002 | WO2002018381A1 6,7-dihydro-pyrrolo[3,4-b]pyridin-5-ones with an anticonvulsive action and methods for producing the same |
| 03/07/2002 | WO2002018380A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | WO2002018379A2 7-oxo pyridopyrimidines |
| 03/07/2002 | WO2002018377A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/07/2002 | WO2002018345A1 Quinoline antibacterial compounds and methods of use thereof |
| 03/07/2002 | WO2002018344A1 Novel ester or amide derivatives |
| 03/07/2002 | WO2002018340A1 GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS |
| 03/07/2002 | WO2002018338A1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 03/07/2002 | WO2002018335A1 Cyclic amine derivatives |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | WO2002018303A2 Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem |
| 03/07/2002 | WO2002017924A1 Method of treatment |
| 03/07/2002 | WO2002017922A1 Bridged nicotine compounds for use in the treatment of cns pathologies |
| 03/07/2002 | WO2002017918A2 Sustained release formulations for growth hormone secretagogues |
| 03/07/2002 | WO2002017916A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001077100A3 Benzoamide piperidine compounds as substance p antagonists |
| 03/07/2002 | WO2001057022A3 Pyrazole compositions useful as inhibitors of erk |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028940 Also benzimidazolyl and imidazo(4,5-b)pyridinyl-substituted; amides; antiatherosclerotic; reduces smooth muscle cell proliferation as well as reduction in lipoproteins, cholesterol and triglycerides |
| 03/07/2002 | US20020028939 Reacting lactone with diamine by heating; polyurethane polymerization catalyst |
| 03/07/2002 | US20020028831 Phenylpyridine derivatives useful as phosphodiesterase inhibitors |
| 03/07/2002 | US20020028829 Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| 03/07/2002 | US20020028815 Novel multicyclic compounds and the use thereof |
| 03/07/2002 | US20020028813 Isoquinoline inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose) polymerase (PARP); treat tissue damage from necrosis or apoptosis, ischemia or reperfusion injury, stroke, senescence diseases |
| 03/07/2002 | US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors |
| 03/07/2002 | US20020028807 5,11-Dihydro-11-ethyl-5-methyl-8-(2-((1-oxido-4-quinolinyl) oxy)ethyl)-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one for example; inhibitor of HIV replication; treating or preventing HIV infection |
| 03/07/2002 | US20020028464 Diagnosis of diabetes |
| 03/07/2002 | DE10042093A1 Antikonvulsiv wirkende 6,7-Dihydro-pyrrolo[3,4-d]pyridin-5-one und Verfahren zu deren Darstellung Anticonvulsant acting 6,7-dihydro-pyrrolo [3,4-d] pyridin-5-one and processes for their representation |
| 03/07/2002 | CA2420535A1 Sustained release formulations for growth hormone secretagogues |
| 03/07/2002 | CA2420286A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | CA2420122A1 7-oxo pyridopyrimidines |
| 03/07/2002 | CA2419699A1 Gem-substituted .alpha. v .beta. 3 integrin antagonists |
| 03/07/2002 | CA2419623A1 Method for treatment of migraine using pde5 inhibitors |
| 03/07/2002 | CA2419616A1 Novel ester or amide derivatives |
| 03/07/2002 | CA2419255A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/06/2002 | EP1184358A2 Process for treatment and purification of the reaction products obtained by reduction with lithium aluminium hydride |
| 03/06/2002 | EP1183258A1 Imidazo-containing heterocyclic compounds, their compositions and uses |
| 03/06/2002 | EP1183255A1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 03/06/2002 | EP1183252A1 New pharmaceutically active compounds |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183025A2 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 03/06/2002 | EP0874845B1 Pyrido (2,3-b) pyrazine derivatives |
| 03/06/2002 | CN1339038A Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 03/06/2002 | CN1339036A Thienylbenzoylbenzapines as vasporessin agonists |
| 03/06/2002 | CN1339035A Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
| 03/06/2002 | CA2356797A1 Combination treatment for depression and anxiety |